WallStreetZenWallStreetZen

How to Buy Cullinan Therapeutics Stock

Cullinan Therapeutics Inc

Cullinan Oncology Inc. , a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States.

Cullinan Therapeutics stock last closed at $17.88, up 3.23% from the previous day, and has increased 66.02% in one year. It has overperformed other stocks in the Biotechnology industry by 0.92 percentage points. Cullinan Therapeutics stock is currently +134.03% from its 52-week low of $7.64, and -13.29% from its 52-week high of $20.62.

As of Apr 17, 2024, there are 43.07M CGEM shares outstanding. The market capitalization of CGEM is $770.01M. In the last 24 hours, 1.26M CGEM shares were traded.

How to Buy Cullinan Therapeutics Stock

Wondering how to invest in Cullinan Therapeutics stock? Here's how.
  1. Decide where to buy Cullinan Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Cullinan Therapeutics stock.
  2. Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Put funds into your investment account: Choose your payment method and add your info.
  4. Research Cullinan Therapeutics stock: The Cullinan Therapeutics ticker symbol is CGEM. Is Cullinan Therapeutics stock a good investment? Should you buy shares of CGEM? How do CGEM's underlying business fundamentals look? Do top analysts think Cullinan Therapeutics is a good buy? Why has CGEM's stock price moved recently? (Hint: Our stock market research tools can help you decide if CGEM is a good stock to buy).
  5. Execute your CGEM trade: Decide if you will purchase CGEM shares at the current market price or use a limit order to buy CGEM stock at a given price.
  6. Watch your investment in CGEM: Create a watchlist to key updates about your new investment in Cullinan Therapeutics stock.

Step 1: Decide where to buy Cullinan Therapeutics stock

You need a brokerage account to access the NASDAQ market and buy CGEM stock.

A brokerage account allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our research, eToro is the best online stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world markets: From Technology to Real Estate, New York to London — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by opening an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've selected the best brokerage, you need to fill out some personal info so you can buy CGEM today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to open a new trading account.
  1. Send your data by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you've created your account on apps for stocks, your next step is to transfer the money for your investment:

Check out the tutorial below to see the process of transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Cullinan Therapeutics stock

After you have selected the best place to buy Cullinan Therapeutics stock, it's very important to analyze their stock prior to investing, so you truly understand the risk and opportunity.

Cullinan Therapeutics shares quick numbers

CGEM Price
$17.88
1w %
4.81%
1y %
66.02%
5y %
N/A
P/E
-4.85x
P/B
1.7x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$153.16M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$770.01M
Next Earnings
May 9, 2024
Next Dividend
N/A

Cullinan Therapeutics Overview

WallStreetZen was built to help average investors perform better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on CGEM's stock page.

Is CGEM stock undervalued or overvalued?

You can use many financial metrics, analyses, models, and charts to gauge CGEM's intrinsic value.

Using relative valuations measures:

  • CGEM may be undervalued based on its P/B ratio of 1.7x, relative to Biotechnology industry P/B ratio of 5.83x

You can access more valuation research on CGEM's stock here.

CGEM Financial Health Summary

Pros:

  • Total CGEM debt is lower than 5 years ago, relative to shareholder equity.
  • There are more short-term assets than short-term liabilities on the CGEM balance sheet.
  • CGEM has $467.07M in cash and short term investments. This is sufficient to cover its annual cash burn of $134.48M.
  • CGEM has cash burn of 134483000. It has enough cash and short-term investments to cover this for at least one year.
  • CGEM has a low debt to equity ratio of 0.07.
  • There are more short-term assets than long-term liabilities on the CGEM balance sheet.

Do Wall Street analysts think it's a good time to buy CGEM stock

Out of 3 Wall Street analysts who monitor CGEM, the consensus analyst rating on Cullinan Therapeutics is a Strong Buy

Please note that analyst ratings are not recommendations, nor are they investment advice.

You can dive deeper into what analysts are projecting on the Cullinan Therapeutics stock forecast page.

CGEM Technicals

SMA10
17.06
SMA20
16.97
SMA50
17.32
SMA100
13.93
SMA200
11.9
MACD
0.15
MACD Signal
0.1
MACD Histogram
0.04
RSI
58.57
Stochastic %K
31.56
Stochastic %D
34.18
StochRSI %K
52.96
StochRSI %D
30.65

How is CGEM performing as a company?

Last year, CGEM revenue was $0.00. During the last two year, CGEM's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 29.02%.

You can analyze CGEM's earnings and revenue performance here.

Who is buying/selling CGEM?

Over the last 12 months, insiders at CGEM have sold more shares than they have bought.

Corrine Savill, Chief Business Officer of CGEM, was the latest CGEM insider to sell. They sold $647,200.00 worth of CGEM stock on Feb 1, 2024.

Learn more about who owns CGEM stock here.

Can I rely on CGEM as an income stream?

No, Cullinan Therapeutics doesn't provide an income stream by paying out dividends.

Get analysis from other investors

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Execute your CGEM trade

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at an exact dollar amount, use a limit order.

Hit the Open button and eToro will place the order.

If you need additional help investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Watch your investment in CGEM

Now that you own some CGEM shares, you'll want to stay up-to-date on your shares.

Create a watchlist to track the most important metrics related to your CGEM stock.

CGEM Feed

How to Buy Stock in Cullinan Therapeutics

To summarize, here are the 6 steps for buying Cullinan Therapeutics stock:

  1. Decide where to buy Cullinan Therapeutics stock
  2. Create a brokerage account
  3. Put funds into your investment account
  4. Research Cullinan Therapeutics stock
  5. Execute your CGEM trade
  6. Watch your investment in CGEM

If you require a brokerage account, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep track of your investment in Cullinan Therapeutics, click below.

NASDAQ: CGEM
$17.88+0.56 (+3.23%)
Updated Apr 17, 2024
Open eToro Account
NASDAQ: CGEM
$17.88+0.56 (+3.23%)
Updated Apr 17, 2024
Open eToro Account

FAQ

How much does it cost to buy one Cullinan Therapeutics share?

As of Apr 17, 2024, it costs $17.88 to buy one share of Cullinan Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $8, you can buy 0.447 shares of CGEM.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Cullinan Therapeutics stock?

According to 3 Wall Street analysts who monitor Cullinan Therapeutics, their consensus recommendation is to buy Cullinan Therapeutics stock.

What is the best way to buy Cullinan Therapeutics stock?

One way to place an order for Cullinan Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.